eXoZymes (NASDAQ:EXOZ) Trading Down 0.4% – Here’s What Happened
by Teresa Graham · The Cerbat GemeXoZymes Inc. (NASDAQ:EXOZ – Get Free Report) shares fell 0.4% during trading on Thursday . The stock traded as low as $10.31 and last traded at $10.4550. 709 shares traded hands during trading, a decline of 90% from the average session volume of 7,382 shares. The stock had previously closed at $10.50.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of eXoZymes in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.
Read Our Latest Stock Analysis on eXoZymes
eXoZymes Stock Performance
The company has a current ratio of 2.51, a quick ratio of 2.51 and a debt-to-equity ratio of 0.02. The stock’s fifty day simple moving average is $8.83 and its 200 day simple moving average is $11.35. The company has a market cap of $87.43 million, a price-to-earnings ratio of -9.55 and a beta of 2.53.
eXoZymes (NASDAQ:EXOZ – Get Free Report) last issued its earnings results on Monday, March 30th. The company reported ($0.31) earnings per share for the quarter.
About eXoZymes
eXoZymes, Inc develops, manufactures and supplies a range of enzymes and reagents designed for molecular biology research and diagnostic applications. The company’s enzyme engineering platform underpins a portfolio of products aimed at supporting nucleic acid purification, amplification and analysis workflows.
Key offerings from eXoZymes include magnetic bead–based nucleic acid extraction kits, DNA polymerases, reverse transcriptases, proteases and custom enzyme services. In addition, the company provides molecular diagnostic test kits designed for pathogen detection, leveraging scalable production processes and quality systems aligned with regulatory standards.
eXoZymes serves academic research institutions, biotechnology and pharmaceutical companies, and clinical diagnostic laboratories worldwide.